Some problems of postmenopausal osteoporosis prevention with hormone replacement therapy.
- Author:
Jian-li LIU
1
Author Information
1. Department of Gynecology, General Hospital of PLA, Beijing 100853, China.
- Publication Type:Journal Article
- MeSH:
Aged;
Drug Therapy, Combination;
Estrogen Replacement Therapy;
Estrogens, Conjugated (USP);
administration & dosage;
Female;
Humans;
Medroxyprogesterone;
administration & dosage;
Middle Aged;
Osteoporosis, Postmenopausal;
prevention & control;
Progesterone Congeners;
administration & dosage
- From:
Acta Academiae Medicinae Sinicae
2003;25(3):240-243
- CountryChina
- Language:Chinese
-
Abstract:
Estrogen deficiency is the one of pathogenetic causes of postmenopausal osteoporosis. Exogenous estrogen may prevent postmenopausal bone loss, so to prevent postmenopausal osteoporosis and osteoporotic fracture. The effect of estrogen on postmenopausal syndrome can not be substituted with other medicine. However, the attention should be paid to the safety of hormone replacement therapy (HRT) during its long term use, and HRT should be used individually.
